Wordt geladen...
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a higher pr...
Bewaard in:
| Gepubliceerd in: | Breast Cancer (Dove Med Press) |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063595/ https://ncbi.nlm.nih.gov/pubmed/27785100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S114659 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|